Damora Therapeutics Inc.
DMRA | NASDAQ
$22.20
-$0.65 (-2.84%)
Sep 22, 2026, 2:33 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 11K | 68K | n/a | n/a | n/a | n/a | 5K | 60K | 77K | 98K | 229K | 367K | 95K | 139K | 164K | 104K | 104K | 118K | 111K | 118K | 112K | 99K |
Gross Profit | -11K | -68K | n/a | n/a | n/a | n/a | -5K | -60K | -77K | -98K | -229K | -367K | -95K | -139K | -164K | -104K | -104K | -118K | -111K | -118K | -112K | -99K |
Operating Income | -34.99M | -30.81M | -201.7M | -3.16M | -3.42M | -2.6M | -2.71M | -3.84M | -4.61M | -5.74M | -5.95M | -5.86M | -11.16M | -13.49M | -13.53M | -13.62M | -17.12M | -16.94M | -13.47M | -12.94M | -12.27M | -13.55M |
Interest Income | 4.06M | 3.07M | 1M | 42K | 50K | 74K | 228K | 146K | 213K | 257K | 340K | 473K | 442K | 434K | 284K | 221K | 156K | 61K | 30K | 35K | 52K | 39K |
Pretax Income | -30.92M | -27.74M | -200.69M | -3.13M | -3.43M | -2.53M | -6.75M | -3.88M | -5.3M | -5.48M | -6.48M | -8.14M | -10.74M | -12.99M | -14.07M | -13.73M | -16.89M | -16.94M | -13.41M | -12.7M | -12.3M | -13.35M |
Net Income | -31.17M | -27.78M | -200.74M | -3.13M | -3.44M | -2.53M | -6.74M | -3.88M | -5.34M | -5.48M | -6.48M | -8.14M | -10.74M | -12.99M | -14.07M | -13.73M | -16.89M | -16.94M | -13.41M | -12.7M | -12.3M | -13.35M |
Selling & General & Admin | 9.44M | 7.03M | 4.07M | 1.74M | 1.96M | 1.92M | 1.69M | 2.69M | 2.7M | 3.18M | 2.95M | 2.94M | 2.98M | 2.99M | 2.59M | 3.02M | 3.31M | 3.59M | 3.24M | 3.07M | 3.52M | 3.46M |
Research & Development | 25.54M | 23.78M | 197.63M | 1.42M | 1.47M | 678K | 1.01M | 1.09M | 1.83M | 2.46M | 2.77M | 2.55M | 8.09M | 10.36M | 10.77M | 10.49M | 13.71M | 13.24M | 10.12M | 9.75M | 8.64M | 9.99M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 34.98M | 30.74M | 201.7M | 3.16M | 3.42M | 2.6M | 2.7M | 3.78M | 4.53M | 5.64M | 5.72M | 5.49M | 11.06M | 13.35M | 13.36M | 13.52M | 17.02M | 16.82M | 13.36M | 12.82M | 12.16M | 13.45M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 34.99M | 30.81M | 201.7M | 3.16M | 3.42M | 2.6M | 2.71M | 3.84M | 4.61M | 5.74M | 5.95M | 5.86M | 11.16M | 13.49M | 13.53M | 13.62M | 17.12M | 16.94M | 13.47M | 12.94M | 12.27M | 13.55M |
Income Tax Expense | 255K | 42K | 44K | n/a | 4K | 2K | -8K | 7K | 42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 61.14M | 34.3M | 1.66M | 1.33M | 1.32M | 1.32M | 1.29M | 1.14M | 1.08M | 1.08M | 1.08M | 1.08M | 1.06M | 1.03M | 1.03M | 1.02M | 1.01M | 1.01M | 1.01M | 1.01M | 1.01M | 1.01M |
Shares Outstanding (Diluted) | 61.14M | 34.3M | 1.66M | 1.33M | 1.32M | 1.32M | 1.29M | 1.14M | 1.08M | 1.08M | 1.08M | 1.08M | 1.06M | 1.03M | 1.03M | 1.02M | 1.01M | 1.01M | 1.01M | 1.01M | 1.01M | 1.01M |
EPS (Basic) | -0.51 | -0.81 | -121.10 | -2.36 | -2.60 | -1.92 | -5.22 | -3.39 | -4.92 | -5.05 | -5.97 | -7.50 | -10.18 | -12.65 | -13.72 | -13.46 | -16.71 | -16.76 | -13.27 | -12.56 | -12.17 | -13.21 |
EPS (Diluted) | -0.51 | -0.81 | -121.10 | -2.36 | -2.60 | -1.92 | -5.22 | -3.39 | -4.92 | -5.05 | -5.97 | -7.50 | -10.18 | -12.65 | -13.72 | -13.46 | -16.71 | -16.76 | -13.27 | -12.56 | -12.17 | -13.21 |
EBITDA | -34.98M | -27.67M | -200.69M | -3.12M | -3.42M | -2.52M | -6.74M | -3.82M | -5.22M | -5.38M | -6.25M | -7.77M | -10.65M | -12.86M | -13.91M | -13.63M | -16.78M | -16.82M | -13.3M | -12.58M | -12.19M | -13.45M |
EBIT | -34.99M | -27.74M | -200.69M | -3.13M | -3.43M | -2.53M | -6.75M | -3.88M | -5.3M | -5.48M | -6.48M | -8.14M | -10.74M | -12.99M | -14.07M | -13.73M | -16.89M | -16.94M | -13.41M | -12.7M | -12.3M | -13.55M |
Depreciation & Amortization | 11K | 68K | 7K | 10K | 9K | 8K | 5K | 60K | 77K | 98K | 229K | 367K | 95K | 139K | 164K | 104K | 104K | 118K | 111K | 118K | 112K | 99K |
Add to Watchlist
Select watchlists to add or remove DMRA